Mekmedco: Case Analysis: Merck-Medco

Decent Essays
Register to read the introduction… Alternative #3. Creating new capabilities may also be obtained through a spinout organization. Merck realizes that its resources and capabilities are insufficient to rapidly move into the pharmacy management area. Most of its resources are devoted to drug research and development. Christensen states that spinout organizations are appropriate when a separate organization is required when the mainstream organization's values are incapable of devoting resources on the new processes or innovation. 6 Furthermore, he states that spinouts should only be used when a threatening disruptive technology requires a different cost structure or when the current size of the opportunity is insignificant relative to the growth needs of the main organizations. Neither of these criteria is relevant to Merck. Services provided by PBM organizations are not disruptive to drug manufacturers. They may be considered as value-added to drug manufacturers. In addition, the size of the opportunity by acquiring a PBM can be significant to a drug manufacturer. Recommendation. It is recommended that Merck select Alternative #1, which is to acquire Medco. Acquiring Medco and its competencies makes the most sense for Merck. According to Merck's 1993 annual reports, its vision is to create the world's first coordinated pharmaceutical care company that will optimize discovery, development, selection, delivery, utilization, and value of prescription drugs. 2 The quickest and most effective manner in which to achieve this vision is through a PBM acquisition. The internal development of pharmacy benefit competencies would be very difficult and time-consuming for Merck. When making its decision, Merck should not view moving into the pharmacy benefit management area as enhancing existing competencies, but rather expanding into a different business within the pharmaceutical industry in which new competencies will be needed. Based on the aforementioned quote by Grant that …show more content…
As applied to pharmaceutical company-PBM mergers, the theory suggests that an integrated manufacturer might charge a rival PBM more for its unique products than it charges its own PBM, thereby placing rival PBMs at a competitive disadvantage. A review of the early market responses to the manufacturer-PBM mergers indicates the "realignment" theory, so far, best explains the effect of vertical integration. Independence may even be a benefit. Caremark, an independent PBM which has supply arrangements with four major drug manufacturers, recently renewed a pharmacy contract covering 150,000 lives when the employer "ruled out two other competing vendors - DPS and Medco - because of their alliance with drug makers." Robert Pfotenhauer, former chief executive officer of Pharmacy Direct Network (the pharmacy-owned PBM), said PDN "has an opportunity to help level the playing field and ensure that there will be fair competition" and is predicted to be "a significant entity that will have some fairly immediate impact on the prescription benefit management world." Bill Jenison, president of Pharmacy Gold, said the pharmaceutical company-PBM mergers will allow his independent PBM to "leverage more enrollment because of our clinical objectivity and independence." With existing PBMs prepared to handle increased market share, and new PBMs forming, the arguments that the manufacturer-PBM mergers increase the barriers to entry into the industry, or foreclose unique products or services, are weakened. Additionally, no pharmaceutical company makes every drug on a formulary list, so the possibility of strict foreclosure is diminished because the PBMs must maintain supplier relationships with other manufacturers. A different issue arises from these continued supplier relationships concerning more subtle ways in which

Related Documents

  • Improved Essays

    The United States have spent far more money on the health care than any other countries. At 17.1% of their gross domestic product on health care, the United States devoted at least 50 percent more of its economy to health care than do other countries (Squires &Anderson, 2015). Even with so much spending on healthcare, people in the United States are still unable to afford the health care prices, particularly the need for prescription drugs. It is difficult for consumers who have already spent money on health coverage, and with high drug cost due to pharmaceuticals’ regulation on price increased the burden for patients to afford the drugs that they need. Drugs are created and manufactured by the pharmaceutical companies where they have the authority…

    • 1525 Words
    • 7 Pages
    Improved Essays
  • Improved Essays

    These mergers and acquisitions have reduced overall costs for business processes and have spread out some financial risks and have increased their market share. This has allowed better negotiating influence with insurers, other medical centers, physicians, and the government. The horizontal and vertical consolidation of healthcare providers has demonstrated lower business costs but increased costs to consumers and insurers that have revealed a disturbing nationwide…

    • 1084 Words
    • 5 Pages
    Improved Essays
  • Decent Essays

    Health organizations are consolidating in order to create economies of scale which decreases the per-unit cost of care while increasing quality of care. More health organizations are forming health systems by becoming vertically integrated, which offer consumers a one stop continuum of care model (Shay et al., 2013). Vertical integration links services that are at different stages in the process of health care. By integrating a continuum of care health organizations are able to enhance quality of patient care and sustainability, in a highly regulated and competitive marketplace.…

    • 154 Words
    • 1 Pages
    Decent Essays
  • Improved Essays

    Medsouth Case Summary

    • 264 Words
    • 2 Pages

    Another interesting tidbit of information that is related to the topic, originates from the FTC or Federal Trade Commission, Advisory Opinion to Miles (02-19-02). The ruling is focused on a review by the Federal Trade Commission in regards to a course of action of MedSouth in the State of Colorado to partially integrate some of its physician members. The ruling highlights relevant facts in regards to the depth of the MedSouths network, that the Federal Trade Commission had to review.…

    • 264 Words
    • 2 Pages
    Improved Essays
  • Improved Essays

    Over Medicated Essay

    • 512 Words
    • 3 Pages

    Last year, pharmacist filled 4,468,929,929 prescriptions in the United States that is an 85 percent increase from just twenty years earlier (Carr, Rabkin, and Skinner 38). With these kinds of numbers, it must be obvious the process to develop drugs in America is working like a well-oiled machine, or is it? Prescription drug companies, the Food and Drug Administration (FDA) and independent research companies including universities all work together to develop improved medications. Each one has an unbiased, independent role to play in the process, however, over the years the unbiased independent part has become blurred. The Federal Government has made changes to regulations and health care policies, consequently, the prescription drug company’s…

    • 512 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    Complex Health Care

    • 641 Words
    • 3 Pages

    Complex health care arrangements include a variety of arrangements within health care organizations to help them survive the economic constraints placed upon them by the public and the government. The consumer demands increased quality and decreased cost. Government organizations such as Medicare and Medicaid are demanding a bigger bang for the buck. When that care is not delivered payments are withheld or penalties incurred on the organization. It has required hospitals and other healthcare organizations to find ways to deliver care more efficiently and for a lower cost (Centers for Medicare and Medicaid, 2106).…

    • 641 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    Business Description CVS Health (CVS) is an integrated pharmacy healthcare provider operating through two major segments, Pharmacy Services (58%) and Retail (42%). Its pharmacy segment provides pharmacy benefit management (PBM) services, the retail segment operates through retail drugstores and retail health clinics. CVS has been steadily rebranding itself as an integrated healthcare company, focusing on retail health clinics and specialty healthcare. It recently completed an acquisition of Omnicare, a long-term care facility provider serving the growing senior population. The company also acquired Target pharmacies and retail clinics.…

    • 598 Words
    • 3 Pages
    Improved Essays
  • Decent Essays

    First, I would roll out a timeline that is realistic to the data for acquiring healthcare clinics and establishing new ones. I believe this was the first problem in the firm’s original model. Next, I would implement an approach to quality improvement (QI). My approach would be business process reengineering which would provide creative, critical thinking to sustain the firm’s competitive advantage while also restructuring newly acquired and established organizations (Burns, Bradley, & Weiner, 2011). To keep the PhyCor from financially hemorrhaging, I would ensure that each healthcare organization secure its equipment and facilities.…

    • 917 Words
    • 4 Pages
    Decent Essays
  • Great Essays

    Epipen Case Study

    • 1781 Words
    • 8 Pages

    It is estimated that there are currently 43 million Americans at risk of anaphylaxis, a life-threatening allergic reaction (“Mylan’s Commitment,” 2016). The majority of these people are in constant possession of an EpiPen, an auto-injector containing epinephrine used to reverse anaphylaxis (“Anaphylaxis,” 2016). However, in recent years the price of the EpiPen has increased substantially; a two-pack currently costs $609 (Pollack, 2016). Because Mylan commands around 85 percent of the epinephrine auto-injector market, almost all of those at risk have been affected (Herrick, 2016: 2). Concerns about drug price increases, like the EpiPen’s, have caused confusion in many people.…

    • 1781 Words
    • 8 Pages
    Great Essays
  • Improved Essays

    The core competencies of Johnson and Johnson (J&J) are: innovation, extensive collaborations, and corporate culture. By understanding that investing in innovations would increase its leadership position, J&J has been spending heavily on research and development (R&D) for many years. They are now among the world’s top spenders in R&D with approximately 12 percent of its sale revenues invested in 9,000 scientists who currently work in research laboratories around the world. There are currently four J&J innovation centers located in Boston, California, London, and Shanghai. Extensive collaborations is another core competency that helps J&J dominate the health-care market.…

    • 802 Words
    • 4 Pages
    Improved Essays
  • Superior Essays

    Davita Case Study

    • 1176 Words
    • 5 Pages

    ASSIGNMENT 1- Da Vita HUMAR RESOURCE MANAGEMENT SEMINAR HMRT-887 Reshma Shivdasani- 1053319 I. Discuss DaVita 's business strategy in light of internal and external factors that we have been discussing in class, and be sure to do a SWOT analysis. The attached industry report and your own research may provide relevant data. Vision of the company: Building the greatest dialysis company the world has ever seen.…

    • 1176 Words
    • 5 Pages
    Superior Essays
  • Great Essays

    Acquisition of new companies will also give Pfizer better distribution channels to reach out within the…

    • 1041 Words
    • 5 Pages
    Great Essays
  • Great Essays

    esentation analyses the events leading up to the 2004 merger between the pharmaceutical companies Sanofi-Synthelabo and Aventis. It reveals the social, commercial and political complexities and challenges of a merger process in which the defence of French national interests and regional capabilities competed with traditional ‘commercial’ narratives before the deal was closed. presentation critically evaluates the competing criteria adopted by government and industry to justify different merger scenarios and considers the implications for pharmaceutical innovation, industry consolidation and M&A theory The American economy greatest market for the pharmaceutical industry in 2004 the tax cuts and the lower interest rates stimulated expansion…

    • 1499 Words
    • 6 Pages
    Great Essays
  • Improved Essays

    Due to Pfizer operates internationally, Pfizer faces foreign exchange risk, geographic risk, and also legal risk. The exposure of foreign risk was due to over 60 percent of Pfizer’s total revenue is from non-U.S. markets. Pfizer able to reduce its geographic risk by operating globally, so any changes of economic condition of one market would not affect others and also Pfizer is vulnerable to legal risks such as patent rights and trademarks. With having drug manufacturing as their core business, the company faces many legal issues related to…

    • 826 Words
    • 4 Pages
    Improved Essays
  • Great Essays

    What is marketing? When most people think of marketing they normally think of the trading and selling of goods and services. Holdford defines marketing as “a process of problem solving, in which marketers attempt to identify and meet the needs of customers. ” Marketing is the exchanges of people in which something of value is traded for the purpose of satisfying needs and wants.…

    • 1041 Words
    • 4 Pages
    Great Essays